Alcista
$59.37
Precio del escenario
$70.160
+1.326 (+1.89%)Al cierre
Centene Corporation is a healthcare company. It provides access to quality healthcare; programs and a range of health solutions that help families and individuals get well. Its segments include Medicaid, Medicare, Commercial and Other. The Medicaid segment includes the Temporary Assistance for Needy Families (TANF) program, Medicaid Expansion programs, the Aged, Blind or Disabled (ABD) program, the Children's Health Insurance Program (CHIP), Long-Term Services and Supports (LTSS), Foster Care, Medicare-Medicaid Plans (MMP), which cover beneficiaries who are dually eligible for Medicaid and Medicare and other state-based programs. The Medicare segment includes Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans and Medicare Prescription Drug Plans. The Commercial segment includes the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products.
Centene Corp (CNC) is a good buy right now due to its current price of $65.36, which is below the average analyst price target of $78. Additionally, the stock has shown a year-to-date change of +56.44%, indicating strong performance. However, the main risk is the forward P/E ratio of 11.22, suggesting potential valuation concerns if earnings do not meet expectations.
BofA
$80
2026-09-11
BofA
2026-09-11
Precio objetivo
$80
Argus
$80
2026-08-11
Argus
2026-08-11
Precio objetivo
$80
JPMorgan
$67
2026-08-04
JPMorgan
2026-08-04
Precio objetivo
$67
Bernstein
$79
2026-08-03
Bernstein
2026-08-03
Precio objetivo
$79
Morgan Stanley
$66
2026-07-29
Morgan Stanley
2026-07-29
Precio objetivo
$66
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.

Centene Launches National Performance-Based Gold Card Program

PA Health & Wellness Recognized Among Top Medicaid Plans for Second Year

UnitedHealth Q3 Earnings Preview and Options Strategy

Centene Partners with Marathon Health for $0 Primary Care Access

Impact of U.S. Midterm Elections on Stock Market Dynamics
Centene Corporation is a healthcare company. It provides access to quality healthcare; programs and a range of health solutions that help families and individuals get well. Its segments include Medicaid, Medicare, Commercial and Other. The Medicaid segment includes the Temporary Assistance for Needy Families (TANF) program, Medicaid Expansion programs, the Aged, Blind or Disabled (ABD) program, the Children's Health Insurance Program (CHIP), Long-Term Services and Supports (LTSS), Foster Care, Medicare-Medicaid Plans (MMP), which cover beneficiaries who are dually eligible for Medicaid and Medicare and other state-based programs. The Medicare segment includes Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans and Medicare Prescription Drug Plans. The Commercial segment includes the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. It operates in the Healthcare sector (HOSPITAL & MEDICAL SERVICE PLANS industry).
Centene Corp (CNC) is a good buy right now due to its current price of $65.36, which is below the average analyst price target of $78. Additionally, the stock has shown a year-to-date change of +56.44%, indicating strong performance. However, the main risk is the forward P/E ratio of 11.22, suggesting potential valuation concerns if earnings do not meet expectations.
17 analysts cover CNC: 12 rate it Buy, 5 Hold and 0 Sell. The average price target is 43.07.
Aún no hay publicaciones
Regístrate o inicia sesión para participarEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.